Scientific publications

Artificial Intelligence Supporting Lung Cancer Screening: Computer Aided Diagnosis Of Lung Lesions Driven By Morphological Feature Extraction

Francesco Grossi [1], Van-Khoa Le [2], Pierre Baudot [2], Charles Voyton [2], Danny francis [2], Elias Munoz [2], Benoît Huet [2] - Affiliations: [1] Division of Medical Oncology, University of Insubria, Varese, Italy, [2] Median Technologies, Valbonne, France.

Poster presented at the ESMO congress in Paris, France – September 9-13, 2022

Challenges To Assess Bone Metastases In Blinded Independent Central Review (BICR) Of Breast Cancer Trials Using Recist 1.1

Sylvain Bodard [1,2], Christine Ojango [3], Antoine Iannessi [3], Laura Balcells [3], Jiawei He [3], Yan Liu [3] - Affiliations: [1] Hôp. Univ. Necker - Enfants Malades (AP-HP), UPC, Paris, France. [2] Lab. d’imagerie biomédicale, CNRS, INSERM, Sorbone Univ., Paris, France. [3] Median Technologies, Valbonne, France

Poster presented at the ESMO congress in Paris, France – September 9-13, 2022

The objectives of this scientific poster are to document the proportion of reader discrepancies of bone lesions on baseline and to evaluate contribution of bone lesion assessment to the overall assessment.

Development and Validation of a Machine Learning Based CADx Designed to Improve Patient Management in Lung Cancer Screening Programs

Pierre Baudot [1], Charles M. Voyton [1], Danny Francis [1], Afef Baili-Laya [1], Vincent Bobin [1], Benjamin Renoust [1], Yan Liu [1], Antoine Iannessi [1], Benoît Huet [1] – Affiliations: [1] Median Technologies, 1800 Route des Crêtes, 06560 Valbonne, France

Scientific paper presentation held on July 15, 2022 at the ECR – European Congress of Radiology, July 13-17, 2022, Vienna, Austria.

Enabling Lung Cancer Screening with iBiopsy® AI-based Software as Medical Device

Yan Liu [1], Benoit Huet [1] – Affiliations: [1] Median Technologies, 1800 Route des Crêtes, 06560 Valbonne, France

Presentation held on July 13, 2022 at the ECR AI Theater – European Congress of Radiology, July 13-17, 2022, Vienna, Austria. The presentation provides an overview of iBiopsy® Lung Cancer Screening CADe/CADx performance.

The adjudication rates between readers in blinded independent central review (BICR) of advanced esophageal cancer trials with or without immune checkpoint initiators as first line therapy

Yan Liu [1], Yi Wang [1], Antoine Iannessi [1] - Affiliations: [1] Median Technologies, Valbonne, France

Poster presented at the ASCO Annual Meeting – June 4-6, 2022.

The objectives of this work are to document the proportion of reader discrepancies, to evaluate reader performance and to provide suggestions for the reduction of read inconsistency.